WO2025201294 - INDOLE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN UP-REGULATION OF MIR
National phase entry is expected:
Publication Number
WO/2025/201294
Publication Date
02.10.2025
International Application No.
PCT/CN2025/084599
International Filing Date
25.03.2025
Title **
[English]
INDOLE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN UP-REGULATION OF MIR
[French]
COMPOSÉ INDOLE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION DANS LA RÉGULATION POSITIVE DE MIR
[Chinese]
一种吲哚类化合物及其制备方法与miR上调应用
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
HU, Hao
LU, Yinsuo
WU, Junjun
CHU, Cuiping
XIAO, Ying
LI, Hongchao
SU, Jianhong
Priority Data
202410356878.2
26.03.2024
CN
202410619490.7
17.05.2024
CN
202410897181.6
04.07.2024
CN
202411012743.0
25.07.2024
CN
202411346727.5
25.09.2024
CN
202510068605.2
15.01.2025
CN
202510329014.6
19.03.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2040 | |
| EPO | Filing, Examination, Granting | 11820 | |
| Japan | Filing, Examination, Granting | 2061 | |
| South Korea | Filing, Examination, Granting | 2129 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,790
Contact Us
Abstract[English]
The present invention relates to the technical field of chemical medicines, and relates to a compound represented by general formula (Ia), or a racemate thereof, or an isomer thereof, or a pharmaceutically acceptable salt thereof, and a use thereof in the preparation of a drug for treating related diseases by regulating the miRNA level.[French]
La présente invention se rapporte au domaine technique des médicaments chimiques, et concerne un composé représenté par la formule générale (Ia), ou un racémate de celui-ci, ou un isomère de celui-ci, ou un sel pharmaceutiquement acceptable de celui-ci, et une utilisation de celui-ci dans la préparation d'un médicament pour le traitement de maladies associées par régulation du taux de miARN.[Chinese]
本发明属于化学药物技术领域，涉及一种通式(Ia)所示的化合物，或其消旋体、或其异构体、或其可药用的盐，以及在制备用于治疗调节miRNA水平相关疾病的药物用途。